Market Overview

J.P. Morgan Thinks Nervo Is About To Take Off, Sees Major Revenues Coming

  • Shares of Nevro Corp (NYSE: NVRO) have appreciated 77.14 percent year to date, shooting up almost to their 52 week high on the morning of December 14.
  • J.P. Morgan’s Michael Weinstein has reiterated an Overweight rating on the company, while raising the price target from $67 to $80.
  • Weinstein has become more bullish on the stock over the past two weeks, given the various developments at the company.

Analyst Michael Weinstein mentioned that the bullish stance on the company, was based on “starting with the IPR decision, followed by the approval of a Senza-specific pass-through payment from CMS, and culminating with Friday’s and Saturday’s sessions and all of our meetings at NANS.”

With regard to NANS, Weinstein stated that clinician feedback suggests that uptake and utilization has been robust in the U.S., with Nevro not only making meaningful inroads into the market, but the market itself accelerating due to the availability of Senza in the U.S. and Nevro’s results.

The U.S. pivotal trial results, expected in 24 months, continue to appear very strong, while discussions regarding the outcomes, paresthesia and pain relief have all clearly shifted in favor of Nevro.

Meetings with management revealed incrementally positive items, such as “(1) management’s salesforce plans for 2016, (2) last week’s announcement of CMS pass-through reimbursement for Senza outpatient use, and (3) an increase in high-quality sales rep interest following the IPR win and the CMS reimbursement decision,” Weinstein added.

Latest Ratings for NVRO

Sep 2020BairdInitiates Coverage OnOutperform
Aug 2020Wells FargoMaintainsOverweight
Aug 2020Canaccord GenuityMaintainsBuy

View More Analyst Ratings for NVRO
View the Latest Analyst Ratings


Related Articles (NVRO)

View Comments and Join the Discussion!

Posted-In: J.P. Morgan Michael WeinsteinAnalyst Color Long Ideas Price Target Reiteration Analyst Ratings Trading Ideas

Latest Ratings

APAB of A SecuritiesMaintains23.0
COPB of A SecuritiesMaintains46.0
CXOB of A SecuritiesMaintains65.0
DVNB of A SecuritiesMaintains18.0
EOGB of A SecuritiesMaintains64.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at